Stevanato Group S.p.A. (STVN) shares are soaring 5.55% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results. The Italian medical packaging company reported earnings that surpassed analyst expectations, demonstrating robust growth and resilience in a challenging market environment.
For the quarter ended March 31, Stevanato reported adjusted earnings of €0.10 per share, beating the FactSet consensus estimate of €0.09. This represents a significant improvement from €0.08 per share in the same quarter last year. Revenue for Q1 reached €256.6 million, comfortably exceeding analysts' expectations of €247.3 million and marking an 8.7% increase year-over-year. The company's net income stood at €26.5 million, outperforming the IBES estimate of €24.8 million.
Adding to the positive sentiment, Stevanato provided a strong outlook for the full year 2025. The company projects revenue between €1,160 million and €1,190 million, with adjusted EBITDA ranging from €288.5 million to €301.8 million. While Stevanato slightly trimmed its full-year adjusted EPS guidance to €0.50-€0.54 from the previous €0.51-€0.55, it remains in line with market expectations. The company also noted its ongoing efforts to mitigate potential impacts, including the ramp-up of its Fishers, Indiana facility, which is expected to help offset any future challenges.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.